Loading stock data…
Loading stock data…
US$3.50
Get one email when FULC crosses your level. Checked every 15 minutes during market hours.
▼ -0.06 (-1.69%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
35.9
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.30
Bullish momentumMACD above its signal line (-0.38).
50-day average
4.79
Price belowShort-term trend reference.
200-day average
8.26
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Fulcrum Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing small-molecule therapies to treat genetically defined rare diseases in areas of high unmet medical need. The company employs proprietary technology to identify drug targets that modulate gene expression, addressing the root causes of gene mis-expression. Its lead product candidate, losmapimod, targets facioscapulohumeral muscular dystrophy (FSHD), a rare and debilitating muscle disorder. Additional prog…
www.fulcrumtx.com0 strong buy · 0 buy · 7 hold · 4 sell · 2 strong sell (13 analysts, 2026-07-01)
5 strong buy · 8 buy · 2 hold · 1 sell · 0 strong sell (16 analysts, 2026-06-01)
5 strong buy · 8 buy · 2 hold · 1 sell · 0 strong sell (16 analysts, 2026-05-01)
5 strong buy · 8 buy · 2 hold · 1 sell · 0 strong sell (16 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-04-27 | -0.3 | -0.25 | ✓ Beat |
| 2026-02-24 | -0.3 | -0.31 | ✗ Miss |
| 2025-10-29 | -0.29 | -0.31 | ✗ Miss |
| 2025-09-21 | 0.38 | 0.48 | ✓ Beat |
| 2025-07-29 | -0.29 | -0.28 | ✓ Beat |
| 2025-05-01 | -0.29 | -0.28 | ✓ Beat |
| 2025-02-25 | -0.29 | -0.31 | ✗ Miss |
| 2024-11-13 | -0.4 | -0.46 | ✗ Miss |
Companies in the same industry, via Finnhub